But losses mount for the home furnishings e-retailer that went public in October.
Drugstore.com’s second-quarter mail-order pharmacy sales grew 22% year-over-year to $18.4 million, as pharmacy sales ordered for in-store pickup at Rite Aid stores grew 4% to $24 million, Drugstore said.
Drugstore.com Inc.’s second-quarter mail-order pharmacy sales grew 22% year-over-year to $18.4 million, as pharmacy sales ordered for in-store pickup at Rite Aid stores grew 4% to $24 million, Drugstore said in a financial statement filed last week for the quarter ended July 3.
Sales growth in Q2 mail-order pharmacy sales, based on orders placed on Drugstore.com or through its call center, reflected an 11% year-over-year increase in the number of orders to 127,000 as well as an increase in the average value per order. Average order value rose along with a 5% increase in pharmaceuticals and a tendency for customers to order quantities of 90 days or more, Drugstore said.
Average net sales per mail-order pharmacy order rose 9.4% to $145. Overall, average net sales per order rose 3% year-over-year to $78.
Store pickup sales are based on orders placed on Drugstore.com, its call center or RiteAid.com (which is powered by Drugstore.com). Average net sales per store pickup order rose 4.2% to $107.
Net non-prescription Q2 sales rose 17% year-over-year to $43.1 million, as average net sales per order rose 2.7% to $57, Drugstore said.
Drugstore reported earlier this month that overall Q2 net sales rose 10% year-over-year to $96.9 million from $87.8 million. Drugstore, which is ranked No. 28 in the Internet Retailer Top 400 Guide to Retail Web Sites, had 2004 sales of $360.1 million.
Drugstore also reported in a statement filed Monday with the Securities and Exchange Commission that San Francisco investor J. Carlo Cannell, managing director of Cannell Capital LLC, has acquired about 4.7 million shares of Drugstore.com Inc. for stake of about 5.1% of the retailer’s outstanding shares. The investment is worth about $16.4 million, based on Drugstore’s closing stock price last Friday of $3.49 per share.